By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Beckman Coulter reported after the close of the market Wednesday that its third-quarter revenues increased 9 percent, with a decline in its Life Sciences segment offset by growth in the Clinical Diagnostics segment.

The Orange County, Calif.-based firm brought in total revenues of $893.8 million for the three-month period ended Sept. 30, compared to $822.8 million for the third quarter of 2009. Beckman beat analysts' consensus estimate of $884.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.